Octave Specialty Group Inc
OSG NYSE Surety Insurance Financials FY2016โFY2025
Last close ยท Oct 23, 2026
$4.75
0.6%What Octave Specialty Group Inc does
No business description yet.
- Legal name
- OCTAVE SPECIALTY GROUP INC
- Fiscal year ends
- December 31, 2025
- Latest annual report
- 10-K ยท Mar 4, 2026
- Accession ยท CIK
- 0001628280-26-014653
0000874501
Revenue and margins
Octave Specialty Group Inc had $251M of revenue in fiscal 2025, up 6.5% on the year before.
Net income and earnings per share
Loss periods are shown in red.
Returns on capital
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Cash flow
Free cash flow was โ in fiscal 2025, โ of revenue. Cash from operations minus capital spending.
Dividends, buybacks and share count
Octave Specialty Group Inc returned $29.9M to shareholders in fiscal 2025. The diluted share count rose 0.5%.
Balance sheet
Cash, debt and the ratios that show how comfortably Octave Specialty Group Inc can carry it.
| Fiscal year end | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Cash and short-term investments | $431M | $513M | $208M | $157M | $215M |
| Debt incl. finance leases | $2.2B | $639M | $508M | $150M | $118M |
| Debt / equity | 2.1x | 0.5x | 0.4x | 0.2x | 0.2x |
| Total assets | $12.3B | $8.0B | $8.4B | $8.1B | $2.2B |
| Total liabilities | $11.2B | $6.6B | $7.0B | $6.9B | $1.1B |
| Shareholders' equity | $1.0B | $1.3B | $1.4B | $798M | $716M |
| Net debt (โ = net cash) | $1.8B | $126M | $300M | โ$7.2M | โ$97.3M |
Insider trades
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. โPlanโ marks trades under a pre-arranged Rule 10b5-1 plan.
Bought, 12 months
$0.0M
0 insiders
Sold, 12 months
$0.0M
0 insiders
Of sales under plans
โ
$0.0M
No open-market insider trades in the last 12 months.
Piotroski F-score
Nine pass/fail tests of profitability, funding and efficiency. 8โ9 is strong, 0โ2 weak.
| Test | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|
| Net income is positive | โ | โ | โ | โ | โ | โ | โ | โ | โ |
| Cash from operations is positive | โ | โ | โ | โ | โ | โ | โ | โ | โ |
| Return on assets rose | โ | โ | โ | โ | โ | โ | โ | โ | โ |
| Cash from operations exceeds net income | โ | โ | โ | โ | โ | โ | โ | โ | โ |
| Debt fell relative to assets | โ | โ | โ | โ | โ | โ | โ | โ | โ |
| Current ratio rose | โ | โ | โ | โ | โ | โ | โ | โ | โ |
| Share count didn't rise | โ | โ | โ | โ | โ | โ | โ | โ | โ |
| Gross margin rose | โ | โ | โ | โ | โ | โ | โ | โ | โ |
| Revenue rose relative to assets | โ | โ | โ | โ | โ | โ | โ | โ | โ |
| F-score | โ / 3 | 4 / 7 | 2 / 7 | 2 / 7 | 3 / 7 | 6 / 7 | 6 / 7 | 4 / 7 | 2 / 7 |
| Accruals ratio | โ0.5% | 9.2% | 0.7% | โ2.0% | 0.9% | โ8.0% | โ2.4% | โ6.8% | โ4.0% |
| Altman Z'' | โ | โ | โ | โ | โ | โ | โ | โ | โ |
10 years of figures
Amounts in USD. Hover a ratioโs name for its definition.
| Fiscal year | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||||
| Revenue | โ | $622M | $511M | $496M | $156M | $282M | $53.6M | $125M | $236M | $251M |
| Interest expense | โ | $120M | $242M | $269M | $222M | $187M | $0.0M | $0.0M | $9.4M | $18.6M |
| Pretax income | โ | โ$284M | $273M | โ$183M | โ$440M | $2.0M | โ$35.7M | โ$24.2M | โ$59.8M | โ$101M |
| Income tax | โ | $44.0M | $5.0M | $32.0M | โ$3.0M | $18.0M | โ$0.5M | $1.0M | $0.9M | $5.2M |
| Net income | โ | โ$329M | $186M | โ$216M | โ$437M | โ$17.0M | $522M | $5.0M | โ$556M | โ$259M |
| Net income to common | โ | โ | โ | โ$216M | โ$437M | โ$28.0M | $522M | $3.6M | โ$556M | โ$262M |
| Diluted EPS | โ | โ$7.25 | $3.99 | โ$4.69 | โ$9.47 | โ$0.61 | $11.48 | $0.18 | โ$11.96 | โ$5.93 |
| Diluted shares | โ | 0.05B | 0.05B | 0.05B | 0.05B | 0.05B | 0.05B | 0.05B | 0.05B | 0.05B |
| Cash flow | ||||||||||
| Cash from operations | โ | โ$221M | โ$1.5B | โ$311M | โ$175M | โ$131M | $1.3B | $200M | $0.8M | โ$52.3M |
| Depreciation and amortization | โ | $1.0M | $1.0M | $0.0M | $1.0M | $2.0M | $0.9M | $5.2M | $19.9M | $42.0M |
| Stock-based compensation | โ | $4.0M | $12.0M | $12.0M | $11.0M | $14.0M | $11.2M | $12.3M | $9.4M | $9.7M |
| Acquisitions | โ | โ | โ | โ | โ$74.0M | $0.0M | $18.4M | $7.0M | $244M | $218M |
| Share buybacks | โ | โ | โ | โ | โ | โ | $14.2M | $4.5M | $11.7M | $29.9M |
| Dividends and buybacks | โ | โ | โ | โ | โ | โ | $14.2M | $4.5M | $11.7M | $29.9M |
| Balance sheet | ||||||||||
| Cash and short-term investments | $91.0M | $624M | $63.0M | $24.0M | $512M | $431M | $513M | $208M | $157M | $215M |
| Total debt | โ | $992M | $2.9B | $2.8B | $2.7B | $2.2B | $639M | $508M | $150M | $118M |
| Goodwill | โ | โ | โ | โ | $46.0M | $46.0M | $46.1M | $69.7M | $418M | $540M |
| Intangible assets | โ | $847M | $719M | $427M | $409M | $362M | $326M | $61.4M | $345M | $475M |
| Total assets | โ | $23.2B | $14.6B | $13.3B | $13.2B | $12.3B | $8.0B | $8.4B | $8.1B | $2.2B |
| Total liabilities | โ | $21.5B | $13.0B | $11.8B | $12.1B | $11.2B | $6.6B | $7.0B | $6.9B | $1.1B |
| Preferred stock | โ | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M |
| Shareholders' equity | $2.0B | $1.4B | $1.6B | $1.5B | $1.1B | $1.0B | $1.3B | $1.4B | $798M | $716M |
| Margins | ||||||||||
| Net margin | โ | โ52.9% | 36.4% | โ43.5% | โ280.1% | โ6.0% | 973.9% | 4.0% | โ235.8% | โ103.1% |
| Returns | ||||||||||
| Return on equity | โ | โ19.6% | 12.5% | โ14.1% | โ34.2% | โ1.6% | 45.6% | 0.4% | โ51.5% | โ34.2% |
| Return on assets | โ | โ1.4% | 1.0% | โ1.5% | โ3.3% | โ0.1% | 5.2% | 0.1% | โ6.7% | โ5.0% |
| Return on tangible equity | โ | โ61.6% | 21.3% | โ20.6% | โ69.9% | โ4.4% | 59.4% | 0.3% | โ1,573.9% | โ |
| Growth | ||||||||||
| Revenue growth | โ | โ | โ17.8% | โ2.9% | โ68.5% | 80.8% | โ81.0% | 132.6% | 89.1% | 6.5% |
| Net income growth | โ | โ | โ | โ216.1% | โ | โ | โ | โ99.1% | โ11,331.8% | โ |
| EPS growth | โ | โ | โ | โ217.5% | โ | โ | โ | โ98.4% | โ6,744.4% | โ |
| Share count change | โ | โ | 0.0% | โ1.3% | 0.4% | 0.8% | โ1.8% | โ0.2% | 2.9% | 0.5% |
| Financial health | ||||||||||
| Debt / equity | โ | 0.7x | 1.8x | 1.9x | 2.5x | 2.1x | 0.5x | 0.4x | 0.2x | 0.2x |
| Capital allocation | ||||||||||
| Stock comp / revenue | โ | 0.6% | 2.3% | 2.4% | 7.1% | 5.0% | 20.9% | 9.8% | 4.0% | 3.9% |
| Quality scores | ||||||||||
| Piotroski F-score | โ | โ | 4.0 | 2.0 | 2.0 | 3.0 | 6.0 | 6.0 | 4.0 | 2.0 |
| Accruals ratio | โ | โ0.5% | 9.2% | 0.7% | โ2.0% | 0.9% | โ8.0% | โ2.4% | โ6.8% | โ4.0% |
Source: SEC EDGAR XBRL filings (CIK 0000874501). Data updated October 24, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only โ not investment advice. Check the original filings before relying on any figure.
